Works matching DE "EBOLA virus disease vaccines"


Results: 157
    1
    2
    3
    4

    Biomedical briefing.

    Published in:
    Nature Medicine, 2015, v. 21, n. 1, p. 6, doi. 10.1038/nm0115-6
    Publication type:
    Article
    5

    Ebola: a call to action.

    Published in:
    Nature Medicine, 2014, v. 20, n. 9, p. 967, doi. 10.1038/nm.3689
    Publication type:
    Article
    6
    7
    8
    9
    10

    Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone.

    Published in:
    Nature, 2015, v. 524, n. 7563, p. 93, doi. 10.1038/nature14490
    By:
    • Tong, Yi-Gang;
    • Shi, Wei-Feng;
    • Liu, Di;
    • Qian, Jun;
    • Liang, Long;
    • Bo, Xiao-Chen;
    • Liu, Jun;
    • Ren, Hong-Guang;
    • Fan, Hang;
    • Ni, Ming;
    • Sun, Yang;
    • Jin, Yuan;
    • Teng, Yue;
    • Li, Zhen;
    • Kargbo, David;
    • Dafae, Foday;
    • Kanu, Alex;
    • Chen, Cheng-Chao;
    • Lan, Zhi-Heng;
    • Jiang, Hui
    Publication type:
    Article
    11
    12

    Trial and triumph.

    Published in:
    Nature, 2015, v. 524, n. 7563, p. 5, doi. 10.1038/524005a
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections.

    Published in:
    PLoS Neglected Tropical Diseases, 2017, v. 11, n. 5, p. 1, doi. 10.1371/journal.pntd.0005645
    By:
    • Cimini, Eleonora;
    • Viola, Domenico;
    • Cabeza-Cabrerizo, Mar;
    • Romanelli, Antonella;
    • Tumino, Nicola;
    • Sacchi, Alessandra;
    • Bordoni, Veronica;
    • Casetti, Rita;
    • Turchi, Federica;
    • Martini, Federico;
    • Bore, Joseph A.;
    • Koundouno, Fara Raymond;
    • Duraffour, Sophie;
    • Michel, Janine;
    • Holm, Tobias;
    • Zekeng, Elsa Gayle;
    • Cowley, Lauren;
    • Garcia Dorival, Isabel;
    • Doerrbecker, Juliane;
    • Hetzelt, Nicole
    Publication type:
    Article
    19

    Containing Ebola at the Source with Ring Vaccination.

    Published in:
    PLoS Neglected Tropical Diseases, 2016, v. 10, n. 11, p. 1, doi. 10.1371/journal.pntd.0005093
    By:
    • Merler, Stefano;
    • Ajelli, Marco;
    • Fumanelli, Laura;
    • Parlamento, Stefano;
    • Pastore y Piontti, Ana;
    • Dean, Natalie E.;
    • Putoto, Giovanni;
    • Carraro, Dante;
    • Jr.Longini, Ira M.;
    • Halloran, M. Elizabeth;
    • Vespignani, Alessandro
    Publication type:
    Article
    20
    21
    22
    23

    Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial.

    Published in:
    2017
    By:
    • Agnandji, Selidji T.;
    • Fernandes, José F.;
    • Bache, Emmanuel B.;
    • Obiang Mba, Régis M.;
    • Brosnahan, Jessica S.;
    • Kabwende, Lumeka;
    • Pitzinger, Paul;
    • Staarink, Pieter;
    • Massinga-Loembe, Marguerite;
    • Krähling, Verena;
    • Biedenkopf, Nadine;
    • Fehling, Sarah Katharina;
    • Strecker, Thomas;
    • Clark, David J.;
    • Staines, Henry M.;
    • Hooper, Jay W.;
    • Silvera, Peter;
    • Moorthy, Vasee;
    • Kieny, Marie-Paule;
    • Adegnika, Akim A.
    Publication type:
    journal article
    24
    25
    26
    27

    Global Health.

    Published in:
    JAMA: Journal of the American Medical Association, 2017, v. 317, n. 7, p. 687
    By:
    • Friedrich, M. J.
    Publication type:
    Article
    28

    Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.

    Published in:
    2016
    By:
    • Milligan, Iain D.;
    • Gibani, Malick M.;
    • Sewell, Richard;
    • Clutterbuck, Elizabeth A.;
    • Campbell, Danielle;
    • Plested, Emma;
    • Nuthall, Elizabeth;
    • Voysey, Merryn;
    • Silva-Reyes, Laura;
    • Juliana McElrath, M.;
    • De Rosa, Stephen C.;
    • Frahm, Nicole;
    • Cohen, Kristen W.;
    • Shukarev, Georgi;
    • Orzabal, Nicola;
    • Duijnhoven, Wilbert van;
    • Truyers, Carla;
    • Bachmayer, Nora;
    • Splinter, Daniel;
    • Samy, Nathaly
    Publication type:
    journal article
    29
    30
    31

    Closer to an Effective Ebola Vaccine.

    Published in:
    JAMA: Journal of the American Medical Association, 2015, v. 313, n. 7, p. 659, doi. 10.1001/jama.2015.0577
    By:
    • Friedrich, M. J.
    Publication type:
    Article
    32

    Experimental Ebola Vaccine.

    Published in:
    JAMA: Journal of the American Medical Association, 2012, v. 307, n. 5, p. 446, doi. 10.1001/jama.2012.71
    By:
    • Hampton, Tracy
    Publication type:
    Article
    33

    News.

    Published in:
    Perspectives in Public Health, 2015, v. 135, n. 2, p. 59, doi. 10.1177/1757913915572755
    Publication type:
    Article
    34
    35

    In the Literature.

    Published in:
    Clinical Infectious Diseases, 2016, v. 62, n. 12, p. iii, doi. 10.1093/cid/civ282
    Publication type:
    Article
    36
    37
    38
    39

    Risk of Misinterpretation of Ebola Virus PCR Results After rVSV ZEBOV-GP Vaccination.

    Published in:
    2015
    By:
    • Cnops, Lieselotte;
    • Gerard, Michèle;
    • Vandenberg, Olivier;
    • Van den Wijngaert, Sigi;
    • Heyndrickx, Leo;
    • Willems, Elisabeth;
    • Demeulemeester, Kathy;
    • De Clerck, Hilde;
    • Dediste, Anne;
    • Callens, Steven;
    • De Munter, Paul;
    • Vlieghe, Erika;
    • Bottieau, Emmanuel;
    • Wuillaume, Francoise;
    • Van Esbroeck, Marjan;
    • Ariën, Kevin K.
    Publication type:
    Letter to the Editor
    40

    1 January News.

    Published in:
    Clinical Infectious Diseases, 2015, v. 60, n. 1, p. i, doi. 10.1093/cid/ciu886
    Publication type:
    Article
    41

    1 December News.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. 11, p. i, doi. 10.1093/cid/ciu771
    Publication type:
    Article
    42
    43
    44
    45
    46

    Author Correction: Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination.

    Published in:
    2020
    By:
    • Pejoski, David;
    • de Rham, Casimir;
    • Martinez-Murillo, Paola;
    • Santoro, Francesco;
    • Auderset, Floriane;
    • Medaglini, Donata;
    • Pozzi, Gianni;
    • Vono, Maria;
    • Lambert, Paul-Henri;
    • Huttner, Angela;
    • Haks, Mariëlle C.;
    • Ottenhoff, Tom H. M.;
    • Villard, Jean;
    • Siegrist, Claire-Anne;
    • the VEBCON Consortium;
    • Addo, Marylyn M.;
    • Agnandji, Selidji Todagbe;
    • Becker, Stephan;
    • Bejon, Philip;
    • Brosnahan, Jessica S.
    Publication type:
    Correction Notice
    47

    Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination.

    Published in:
    NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-0179-4
    By:
    • Pejoski, David;
    • de Rham, Casimir;
    • Martinez-Murillo, Paola;
    • Santoro, Francesco;
    • Auderset, Floriane;
    • Medaglini, Donata;
    • Pozzi, Gianni;
    • Vono, Maria;
    • Lambert, Paul-Henri;
    • Huttner, Angela;
    • Haks, Mariëlle C.;
    • Ottenhoff, Tom H. M.;
    • Villard, Jean;
    • Siegrist, Claire-Anne;
    • the VEBCON Consortium;
    • Addo, Marylyn M.;
    • Agnandji, Selidji Todagbe;
    • Becker, Stephan;
    • Bejon, Philip;
    • Brosnahan, Jessica S.
    Publication type:
    Article
    48
    49
    50